Clinical Trial Update: A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating immune response and safety of two doses of GSK's HRV liquid vaccine in healthy infants; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• HRV liquid vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus, Rotavirus Vaccines | Phase 2 | Status: COMPLETED | Results posted: 2017-09-11